Naviter Wealth’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $723K | Buy |
46,560
+35,673
| +328% | +$554K | 0.09% | 177 |
|
|
2025
Q1 | $164K | Sell |
10,887
-6,340
| -37% | -$95.4K | 0.02% | 259 |
|
|
2024
Q4 | $228K | Sell |
17,227
-68,248
| -80% | -$904K | 0.03% | 255 |
|
|
2024
Q3 | $1.22M | Buy |
85,475
+6,319
| +8% | +$89.9K | 0.17% | 149 |
|
|
2024
Q2 | $1.02M | Buy |
79,156
+9,690
| +14% | +$125K | 0.15% | 159 |
|
|
2024
Q1 | $965K | Buy |
69,466
+17,462
| +34% | +$243K | 0.16% | 157 |
|
|
2023
Q4 | $742K | Sell |
52,004
-1,615
| -3% | -$23K | 0.15% | 157 |
|
|
2023
Q3 | $829K | Buy |
53,619
+4,953
| +10% | +$76.6K | 0.2% | 125 |
|
|
2023
Q2 | $765K | Buy |
48,666
+6,520
| +15% | +$102K | 0.19% | 133 |
|
|
2023
Q1 | $695K | Buy |
42,146
+8,710
| +26% | +$144K | 0.24% | 118 |
|
|
2022
Q4 | $539K | Buy |
33,436
+2,477
| +8% | +$40K | 0.15% | 144 |
|
|
2022
Q3 | $402K | Buy |
30,959
+1,571
| +5% | +$20.4K | 0.16% | 143 |
|
|
2022
Q2 | $413K | Buy |
+29,388
| New | +$413K | 0.17% | 137 |
|